Repetitive high-dose ifosfamide, thiotepa and paclitaxel (ITP) with peripheral blood progenitor cell support; A novel outpatient regimen for metastatic and locally advanced breast cancer.

被引：0
|
作者：
Prince, HM [1 ]
Millward, MJ [1 ]
Rischin, DR [1 ]
Blakey, D [1 ]
Wolf, M [1 ]
Januscewicz, H [1 ]
Toner, G [1 ]
Richardson, G [1 ]
Sharkey, P [1 ]
Dale, B [1 ]
机构：
[1] PETER MACCALLUM CANC INST,BLOOD & MARROW TRANSPLANT SERV,MELBOURNE,VIC 3000,AUSTRALIA
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4575 / 4575
页数：1
相关论文
共 50 条
  • [1] Repetitive high-dose therapy with ifosfamide, thiotepa and paclitaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: Results of a phase I study
    Prince, HM
    Millward, MJ
    Rischin, D
    Blakey, D
    Francis, P
    Gates, P
    Chapple, P
    Quinn, M
    Juneja, S
    Wolf, M
    Januszewicz, EH
    Seymour, JF
    Brettell, M
    Strickland, A
    Zalcberg, J
    Richardson, G
    Scarlett, J
    Briggs, P
    Toner, GC
    ANNALS OF ONCOLOGY, 1999, 10 (04) : 479 - 481
  • [2] Repetitive high-dose therapy with ifosfamide, thiotepa and paclitaxel (ITP) with blood cell (BC) support for metastatic breast cancer (MBC): Results of a phase I study
    Prince, HM
    Millward, MJ
    Rischin, D
    Blakey, D
    Wolf, M
    Januscewicz, H
    Toner, G
    Bertoncello, I
    Richardson, G
    Briggs, P
    Scarlett, J
    Gates, P
    Dale, B
    EXPERIMENTAL HEMATOLOGY, 1998, 26 (08) : 701 - 701
  • [3] Repetitive high-dose therapy with peripheral blood progenitor cell (PBPC) support for metastatic (MBC) and locally advanced breast cancer
    不详
    Bone Marrow Transplantation, 2000, 26 (Suppl 1) : S7 - S8
  • [4] Repetitive high-dose therapy with cyclophosphamide, thiotepa and docetaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I study
    HM Prince
    D Rischin
    GC Toner
    JF Seymour
    D Blakey
    P Gates
    S Eerhard
    P Chapple
    M Quinn
    M Brettell
    S Juneja
    M Wolf
    EH Januszewicz
    G Richardson
    J Scarlett
    P Briggs
    Bone Marrow Transplantation, 2000, 26 : 955 - 961
  • [5] Repetitive high-dose therapy with cyclophosphamide, thiotepa and docetaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I study
    Prince, HM
    Rischin, D
    Toner, GC
    Seymour, JF
    Blakey, D
    Gates, P
    Eerhard, S
    Chapple, P
    Quinn, M
    Brettell, M
    Juneja, S
    Wolf, M
    Januszewicz, EH
    Richardson, G
    Scarlett, J
    Briggs, P
    BONE MARROW TRANSPLANTATION, 2000, 26 (09) : 955 - 961
  • [6] High-dose therapy with peripheral blood progenitor cell support (PBPC) for the treatment of advanced breast cancer
    Fersis, N
    Haas, R
    Wallwiener, D
    Hohaus, S
    Huober, J
    Bastert, G
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 661 - 661
  • [7] High-dose therapy with peripheral blood progenitor cell support (PBPC) for the treatment of advanced breast cancer
    Fersis, N
    Haas, R
    Wallwiener, D
    Hohaus, S
    Fruhauf, S
    Bastert, G
    BREAST, 1997, 6 (05): : 321 - 321
  • [8] Tandem high-dose chemotherapy with autologous peripheral blood stem cell support in metastatic breast cancer.
    Myhand, R
    Atkins, M
    Coleman, T
    Reeb, B
    Smith, D
    Alexander, B
    Vukelja, SJ
    BLOOD, 1997, 90 (10) : 4571 - 4571
  • [9] Dose escalation of paclitaxel with high-dose carboplatin using peripheral blood progenitor cell support in patients with advanced ovarian cancer
    Fennelly, DW
    Aghajanian, C
    Shapiro, F
    OFlaherty, C
    OConnor, K
    Curtin, JP
    Crown, JP
    Hoskins, WJ
    Spriggs, DR
    SEMINARS IN ONCOLOGY, 1997, 24 (01) : S26 - S30
  • [10] Phase II trial of sequential high-dose chemotherapy with paclitaxel, melphalan and cyclophosphamide, thiotepa and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancer
    LT Vahdat
    C Balmaceda
    K Papadopoulos
    D Frederick
    D Donovan
    E Sharpe
    E Kaufman
    D Savage
    A Tiersten
    G Nichols
    J Haythe
    A Troxel
    K Antman
    CS Hesdorffer
    Bone Marrow Transplantation, 2002, 30 : 149 - 155
12345